Search

Search Constraints

You searched for: Author/Creator Scott, Iain

Search Results

1. Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling. Issue 12 (19th June 2019)

3. Adropin reduces blood glucose levels in mice by limiting hepatic glucose production. Issue 8 (19th April 2019)

6. Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice. (April 2019)

8. BS3 GCN5L1 promotes diastolic dysfunction by inhibiting cardiac pyruvate oxidation. (6th June 2022)

9. GCN5L1 impairs diastolic function in mice exposed to a high fat diet by restricting cardiac pyruvate oxidation. Issue 15 (3rd August 2022)